[{"edinetCode":"E00924","endDate":"2017\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":7280.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":396711000.0,"sharesOwendPercent":0.7066,"outstandingShares":null,"numberOfSubsidiary":null,"bps":1483.35,"equityRatio":0.882,"cashAndCashEquivalents":113223000000.0,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":50984000000.0,"eps":99.19,"dilutedEps":null,"dividendPerShare":null,"per":23.4,"roe":0.068,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2017\/6\/21","stockCode":4508,"accountingYear":"第10期（自　2016年４月１日　至　2017年３月31日）","accountingYearStart":"2016\/4\/1","accountingYearEnd":"2017\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00924","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":50000,"settlementDate":"2022\/3\/31","submitterName":"田辺三菱製薬株式会社","submitterNameEnglish":"Mitsubishi Tanabe Pharma Corporation","submitterNameKana":"タナベミツビシセイヤクカブシキガイシャ","location":"大阪市中央区道修町三丁目２番１０号","industory":"医薬品","corporateNumber":9120000000000.0},{"edinetCode":"E00924","endDate":"2018\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":7187.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":402185000.0,"sharesOwendPercent":0.7169,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":20.1,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2018\/6\/22","stockCode":4508,"accountingYear":"第11期（自　2017年４月１日　至　2018年３月31日）","accountingYearStart":"2017\/4\/1","accountingYearEnd":"2018\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00924","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":50000,"settlementDate":"2022\/3\/31","submitterName":"田辺三菱製薬株式会社","submitterNameEnglish":"Mitsubishi Tanabe Pharma Corporation","submitterNameKana":"タナベミツビシセイヤクカブシキガイシャ","location":"大阪市中央区道修町三丁目２番１０号","industory":"医薬品","corporateNumber":9120000000000.0},{"edinetCode":"E00924","endDate":"2019\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":7228.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":398007000.0,"sharesOwendPercent":0.7095,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":1056290000000.0,"currentAssets":588433000000.0,"fixedAsset":null,"tangibleFixedAssets":73338000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":145954000000.0,"currentLiabilities":91699000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":50000000000.0,"capitalSurplus":451253000000.0,"accumulatedEarnings":387964000000.0,"treasuryStock":-1040000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":180646000000.0,"grossProfit":null,"sgaExpenses":98725000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":22.2,"roe":null,"cashFlowFromOperatingActivities":41460000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-31212000000.0,"cashFlowFromFinancialActivities":-25869000000.0,"changesInCashAndCashEquivalents":-15090000000.0,"列1":"asr","submitDate":"2019\/6\/21","stockCode":4508,"accountingYear":"第12期（自　2018年４月１日　至　2019年３月31日）","accountingYearStart":"2018\/4\/1","accountingYearEnd":"2019\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00924","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":50000,"settlementDate":"2022\/3\/31","submitterName":"田辺三菱製薬株式会社","submitterNameEnglish":"Mitsubishi Tanabe Pharma Corporation","submitterNameKana":"タナベミツビシセイヤクカブシキガイシャ","location":"大阪市中央区道修町三丁目２番１０号","industory":"医薬品","corporateNumber":9120000000000.0},{"edinetCode":"E00924","endDate":"2019\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":1045460000000.0,"currentAssets":574671000000.0,"fixedAsset":null,"tangibleFixedAssets":83340000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":151511000000.0,"currentLiabilities":86661000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":50000000000.0,"capitalSurplus":449993000000.0,"accumulatedEarnings":379732000000.0,"treasuryStock":-1040000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":44764000000.0,"grossProfit":null,"sgaExpenses":22949000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":5243000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":6775000000.0,"cashFlowFromFinancialActivities":-17669000000.0,"changesInCashAndCashEquivalents":-6561000000.0,"列1":"q1r","submitDate":"2019\/8\/5","stockCode":4508,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00924","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":50000,"settlementDate":"2022\/3\/31","submitterName":"田辺三菱製薬株式会社","submitterNameEnglish":"Mitsubishi Tanabe Pharma Corporation","submitterNameKana":"タナベミツビシセイヤクカブシキガイシャ","location":"大阪市中央区道修町三丁目２番１０号","industory":"医薬品","corporateNumber":9120000000000.0},{"edinetCode":"E00924","endDate":"2019\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":399336000.0,"sharesOwendPercent":0.7118,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":1055880000000.0,"currentAssets":590125000000.0,"fixedAsset":null,"tangibleFixedAssets":80837000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":162294000000.0,"currentLiabilities":88841000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":50000000000.0,"capitalSurplus":449620000000.0,"accumulatedEarnings":381765000000.0,"treasuryStock":-1018000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":88508000000.0,"grossProfit":null,"sgaExpenses":47562000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":19487000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-21936000000.0,"cashFlowFromFinancialActivities":-19783000000.0,"changesInCashAndCashEquivalents":-23395000000.0,"列1":"q2r","submitDate":"2019\/11\/6","stockCode":4508,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00924","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":50000,"settlementDate":"2022\/3\/31","submitterName":"田辺三菱製薬株式会社","submitterNameEnglish":"Mitsubishi Tanabe Pharma Corporation","submitterNameKana":"タナベミツビシセイヤクカブシキガイシャ","location":"大阪市中央区道修町三丁目２番１０号","industory":"医薬品","corporateNumber":9120000000000.0},{"edinetCode":"E00924","endDate":"2019\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":1077550000000.0,"currentAssets":603933000000.0,"fixedAsset":null,"tangibleFixedAssets":83782000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":186831000000.0,"currentLiabilities":100243000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":50000000000.0,"capitalSurplus":448704000000.0,"accumulatedEarnings":377592000000.0,"treasuryStock":-1022000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":143065000000.0,"grossProfit":null,"sgaExpenses":71279000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":32292000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-10382000000.0,"cashFlowFromFinancialActivities":-35726000000.0,"changesInCashAndCashEquivalents":-14283000000.0,"列1":"q3r","submitDate":"2020\/2\/7","stockCode":4508,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00924","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":50000,"settlementDate":"2022\/3\/31","submitterName":"田辺三菱製薬株式会社","submitterNameEnglish":"Mitsubishi Tanabe Pharma Corporation","submitterNameKana":"タナベミツビシセイヤクカブシキガイシャ","location":"大阪市中央区道修町三丁目２番１０号","industory":"医薬品","corporateNumber":9120000000000.0}]